N. Murugina

SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia

G. Chkadua, B. Pinegin, M. Pashenkov, 2020, The Journal of Biological Chemistry.

SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study.

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Synergistic interactions between NOD receptors and TLRs: Mechanisms and clinical implications

B. Pinegin, M. Pashenkov, A. Budikhina, 2018, Journal of leukocyte biology.

Interplay between NOD1 and TLR4 Receptors in Macrophages: Nonsynergistic Activation of Signaling Pathways Results in Synergistic Induction of Proinflammatory Gene Expression

G. Chkadua, B. Pinegin, M. Pashenkov, 2021, The Journal of Immunology.

Reduced Degranulation of NK Cells in Patients with Frequently Recurring Herpes

B. Pinegin, M. Pashenkov, V. Murugin, 2011, Clinical and Vaccine Immunology.

The influence of glatiramer acetate on Th17-immune response in multiple sclerosis

A. Boyko, M. Pashenkov, V. Murugin, 2020, PloS one.

A prospective study of the protective effect of SARS-CoV-2-specific antibodies and T cells in Moscow residents

A. Mohammad, N. Pinegina, A. Deryabin, 2021, medRxiv.